Aqua Medical
Greg Wilson is an experienced financial executive with a strong background in consulting and corporate finance. Currently serving as Consulting CFO for multiple organizations including Aqua Medical Inc., Aqua Heart, Inc., Aqua Therapeutics, and Que Oncology Pty Ltd since 2017, Wilson has cultivated expertise in managing financial strategies for various companies in the medical and biotechnology sectors. Additionally, Wilson holds a long-term position as CFO at Eurekster, Inc. since 2004. Previous consulting roles include positions at Sardona Therapeutics and Cleave Biosciences. Wilson's academic credentials include an MBA in Finance/Accounting from the University of Colorado Denver and a BS in Biological Science from Colorado State University.
This person is not in any teams
This person is not in any offices
Aqua Medical
Aqua Medical developed a vapor-based, endoscopic, ablation technology to treat gastrointestinal disease and prevent GI cancers. The company's ablation technology is consists of high-temperature water vapor created by a radiofrequency generator that delivers endoscopically through proprietary catheters to the GI tract.Aqua Medical was foundedin 2016 by Virender K. Sharma and is based in Santa Ana, California, United States.